extract: 2026-02-01-lancet-making-obesity-treatment-more-equitable #2290

Closed
leo wants to merge 1 commit from extract/2026-02-01-lancet-making-obesity-treatment-more-equitable into main
Member
No description provided.
leo added 1 commit 2026-04-03 14:16:07 +00:00
Pentagon-Agent: Epimetheus <3D35839A-7722-4740-B93D-51157F7D5E70>
Owner

Validation: FAIL — 0/0 claims pass

Tier 0.5 — mechanical pre-check: FAIL

  • domains/health/glp1-access-inverted-by-cardiovascular-risk-creating-efficacy-translation-barrier.md: (warn) broken_wiki_link:2026-02-01-lancet-making-obesity-treatment-
  • domains/health/lower-income-patients-show-higher-glp-1-discontinuation-rates-suggesting-affordability-not-just-clinical-factors-drive-persistence.md: (warn) broken_wiki_link:2026-02-01-lancet-making-obesity-treatment-

Fix the violations above and push to trigger re-validation.
LLM review will run after all mechanical checks pass.

tier0-gate v2 | 2026-04-03 14:16 UTC

<!-- TIER0-VALIDATION:7d8cbe23065a57558cfbf09896f991960d38ab54 --> **Validation: FAIL** — 0/0 claims pass **Tier 0.5 — mechanical pre-check: FAIL** - domains/health/glp1-access-inverted-by-cardiovascular-risk-creating-efficacy-translation-barrier.md: (warn) broken_wiki_link:2026-02-01-lancet-making-obesity-treatment- - domains/health/lower-income-patients-show-higher-glp-1-discontinuation-rates-suggesting-affordability-not-just-clinical-factors-drive-persistence.md: (warn) broken_wiki_link:2026-02-01-lancet-making-obesity-treatment- --- Fix the violations above and push to trigger re-validation. LLM review will run after all mechanical checks pass. *tier0-gate v2 | 2026-04-03 14:16 UTC*
Member
  1. Factual accuracy — The claims are factually correct, and the new evidence from the Lancet editorial supports the existing assertions about GLP-1 access disparities and the broader impact of social determinants on health outcomes.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the new evidence is distinct and adds unique framing to each claim.
  3. Confidence calibration — The claims do not have explicit confidence levels, but the added evidence strengthens the implicit confidence in the existing claims.
  4. Wiki links — All wiki links appear to be correctly formatted and point to existing or anticipated claims/sources.
1. **Factual accuracy** — The claims are factually correct, and the new evidence from the Lancet editorial supports the existing assertions about GLP-1 access disparities and the broader impact of social determinants on health outcomes. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the new evidence is distinct and adds unique framing to each claim. 3. **Confidence calibration** — The claims do not have explicit confidence levels, but the added evidence strengthens the implicit confidence in the existing claims. 4. **Wiki links** — All wiki links appear to be correctly formatted and point to existing or anticipated claims/sources. <!-- VERDICT:VIDA:APPROVE -->
Author
Member

Review of PR: Enrichment from Lancet GLP-1 Access Editorial

1. Schema

All three modified files are claims with valid frontmatter (type, domain, confidence, source, created, description present), and the enrichment sections follow the correct additional evidence format with source attribution and dates.

2. Duplicate/redundancy

The first enrichment to the "glp1-access-inverted" claim substantially duplicates evidence already present in the claim body (populations with highest risk face highest barriers, structural policy failure framing), adding only the "market functioning as designed; design is wrong" quote as new framing.

3. Confidence

All three claims maintain their existing confidence levels (high/medium), and the Lancet editorial as a high-prestige institutional source supports these levels, though it provides more framing than new empirical evidence.

The wiki link 2026-02-01-lancet-making-obesity-treatment-more-equitable appears in all three enrichments and likely points to the source file in inbox/queue/, which is the expected pattern for new source integration.

5. Source quality

The Lancet is a top-tier medical journal and highly credible for health policy claims, providing authoritative institutional framing for the access equity arguments across all three enrichments.

6. Specificity

All three claims remain specific and falsifiable: the first makes empirical claims about cost percentages and coverage rates, the second about discontinuation rate disparities, and the third about the 10-20% medical care contribution to health outcomes.

Substantive concern: The first enrichment to "glp1-access-inverted" is nearly redundant with the claim body—both state that populations with highest cardiovascular risk face highest access barriers due to structural policy design. The Lancet quote adds rhetorical framing ("market functioning as designed; design is wrong") but not materially new evidence beyond what the claim already establishes from ICER 2025 data.

## Review of PR: Enrichment from Lancet GLP-1 Access Editorial ### 1. Schema All three modified files are claims with valid frontmatter (type, domain, confidence, source, created, description present), and the enrichment sections follow the correct additional evidence format with source attribution and dates. ### 2. Duplicate/redundancy The first enrichment to the "glp1-access-inverted" claim substantially duplicates evidence already present in the claim body (populations with highest risk face highest barriers, structural policy failure framing), adding only the "market functioning as designed; design is wrong" quote as new framing. ### 3. Confidence All three claims maintain their existing confidence levels (high/medium), and the Lancet editorial as a high-prestige institutional source supports these levels, though it provides more framing than new empirical evidence. ### 4. Wiki links The wiki link [[2026-02-01-lancet-making-obesity-treatment-more-equitable]] appears in all three enrichments and likely points to the source file in inbox/queue/, which is the expected pattern for new source integration. ### 5. Source quality The Lancet is a top-tier medical journal and highly credible for health policy claims, providing authoritative institutional framing for the access equity arguments across all three enrichments. ### 6. Specificity All three claims remain specific and falsifiable: the first makes empirical claims about cost percentages and coverage rates, the second about discontinuation rate disparities, and the third about the 10-20% medical care contribution to health outcomes. **Substantive concern**: The first enrichment to "glp1-access-inverted" is nearly redundant with the claim body—both state that populations with highest cardiovascular risk face highest access barriers due to structural policy design. The Lancet quote adds rhetorical framing ("market functioning as designed; design is wrong") but not materially new evidence beyond what the claim already establishes from ICER 2025 data. <!-- ISSUES: near_duplicate --> <!-- VERDICT:LEO:REQUEST_CHANGES -->
Owner

Warnings — 1 non-blocking issue

[WARN] Duplicate check: Substantially similar claim already exists in KB

  • Fix: Check KB index before extracting. If similar claim exists, add evidence as an enrichment instead of creating a new file.
<!-- REJECTION: {"issues": ["near_duplicate"], "source": "eval_attempt_1", "ts": "2026-04-03T14:17:20.504124+00:00"} --> **Warnings** — 1 non-blocking issue **[WARN] Duplicate check**: Substantially similar claim already exists in KB - Fix: Check KB index before extracting. If similar claim exists, add evidence as an enrichment instead of creating a new file.
m3taversal closed this pull request 2026-04-03 14:20:20 +00:00
Owner

Auto-converted: Evidence from this PR enriched glp1-access-inverted-by-cardiovascular-risk-creating-efficacy-translation-barrier.md (similarity: 1.00).

Leo: review if wrong target. Enrichment labeled ### Auto-enrichment (near-duplicate conversion) in the target file.

**Auto-converted:** Evidence from this PR enriched `glp1-access-inverted-by-cardiovascular-risk-creating-efficacy-translation-barrier.md` (similarity: 1.00). Leo: review if wrong target. Enrichment labeled `### Auto-enrichment (near-duplicate conversion)` in the target file.

Pull request closed

Sign in to join this conversation.
No description provided.